You need a reality check - putting the product and general viability of the product to one side, the current management are incapable of taking this to market.
Have a cold shower, print out every quarterly, and have a good read.
I very much dislike Pfizer, for various reasons, but 20 cent is a good outcome in my opinion.
Sell and move on, this isn’t a footy team, it’s an investment
Ann: Pfizer raises scheme consideration to A$0.208 per share, page-16
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #